CJC-1295 Research
aidsmap 2006 — CJC-1295 Phase 2 Death Report
Summary
Documents the July 2006 halt of NCT00267527; male participant died ~2-3 hours after 11th weekly injection
Study Details
Study Design
News report of regulatory event
Indication
HIV-associated visceral obesity/lipodystrophy
Risk of Bias Assessment
Contemporaneous reporting; based on ConjuChem press release
Tags
SourceNewsRegulatory DisclosureCjc 1295With DACPhase 2 DeathSafety Event
Metrics
Citations
0Evidence QualityN/A
Related PeptideCJC-12956 papers